Atlas Trials

First in Man Evaluation of Single and Multiple Doses of Oral ATX2417

Clinical trial NCT02316912 · COMPLETED

Trial details

NCT number
NCT02316912
Sponsor
Atopix Therapeutics, Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergy
Start date
2015-02-01
Primary completion
2016-04-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.